The Journal of Organic Chemistry
Note
NMR spectra were recorded in D2O at 101 and 162 MHz using a
Bruker AVANCE 400 Plus Nanobay instrument and a Bruker
AVANCE 500 instrument fitted with a cryoprobe, respectively.
Chemical shifts (δ) are given in ppm and referenced to the internal
solvent signal used as an internal standard. Assignments in the NMR
spectra were made by first-order analysis of the spectra and were
supported by 1H−1H COSY, 1H−13C HMQC correlation results.
High-resolution mass spectrometry was performed on a Waters
Synapt G2-S HDMS spectrometer. Optical rotation measurements
were carried out on a Horiba SEPA-300 instrument. Unless otherwise
stated, all of the commercially available solvents and reagents were
purchased from FUJIFILM Wako Pure Chemical Corporation and
Merck KGaA without further purification. During purification by silica
gel column chromatography, the absorbances of all fractions were
measured at 262 nm using a Shimadzu UV-1280 detector. HPLC
analysis was performed on a Shimadzu HPLC system equipped with a
TSKgel Amide-80 column (Tosoh Bioscience, 4.6 mm × 250 mm, 5
μm). The HPLC system consisted of a system controller (CBM-20A),
a diode array detector (SPD-M20A), a pump (LC-20AD), an
autosampler (SIL-20AC), a column oven (CTO-20AC), and a
degasser (DGU-20As).
General Procedure for Investigating the Effect of Different
Bases (Table 1). The sugar (11 μmol) was dissolved in H2O/
CH3CN (2:1, 44 μL), and 3.3 equiv of DMC (36 μmol) dissolved in
H2O/CH3CN (2:1, 22 μL) was added. Subsequently, 10 equiv of the
base (220 μmol) and 5.0 equiv of UDP (55 μmol) were added to the
solution, and the mixture was stirred until all components had
completely dissolved. After stirring at 4 °C for 1 h, the reaction
mixture was collected and diluted 100 times with water. The diluted
solution was analyzed using HPLC to calculate the product yields.
General Procedure for Investigating the Effect of Different
Reaction Solvents (Table 2). The sugar (11 μmol) was dissolved in
the desired solvent (2:1, 44 μL), and 3.3 equiv of DMC (36 μmol)
dissolved in the desired solvent (2:1, 22 μL) was added. Subsequently,
10 equiv of Et3N (220 μmol) and 5.0 equiv of UDP (55 μmol) were
added to the solution, and the mixture was stirred until all of the
components had completely dissolved. After stirring at 4 or 25 °C for
1 h, the reaction mixture was collected and diluted 100 times with
water. The diluted solution was analyzed using HPLC to calculate the
product yields.
73.7 (C-2′), 73.6 (C-2), 69.7 (C-3′), 69.4 (C-4), 65.0 (C-5′), 60.8
(C-6); 31P NMR (162 MHz, D2O) δ −11.37 (d, JP,P = 16.2 Hz),
−13.11 (d); HRMS (ESI/Q-TOF) m/z [M − H]− calcd for
−
C15H23N2O17P2 565.0477, found 565.0475; [α]2D6.4 −11.7 (10−1 deg
cm2 g−1) (c 3.216 × 10−3, H2O).
Uridine 5′-Monophospho-β-D-glucopyranose, 2. D-Glucose (16
mg, 87 μmol) was dissolved in H2O/CH3CN (2:1, 200 μL), and
DMC (46 mg, 269 μmol) dissolved in H2O/CH3CN (2:1, 150 μL)
was added to the resulting solution. Subsequently, Et3N (148 μL, 1.06
mmol) and UMP (32 mg, 87 μmol) were added to the solution, and
the mixture was stirred at 4 °C for 1 day. The reaction mixture was
then purified by silica gel chromatography using a solvent
composition and gradient of 9:2:1 → 8:2:1 → 6:2:1 → 5:2:1 →
4:2:1 → 3:2:1 (v/v/v) ethyl acetate/methanol/H2O. The absorbance
of each fraction was measured at 262 nm, and the combined fractions
were evaporated to give UMP-glucose 2 (9 mg, 18%): 1H NMR (400
MHz, D2O) δ 7.95 (d, 1.0H, J5″,6′′ = 8.1 Hz, H-6″), 6.00−5.95 (m,
2.0H, H-1′, H-5′′), 4.93 (dd, 1.0H, J1,P = 7.6 Hz, J1,2 = 7.6 Hz, H-1),
4.39−4.35 (m, 2.0H, H-2′, H-3′), 4.29−4.14 (m, 3.0H, H-4′, H-5a′,
H-5b′), 3.92 (dd, 1.0H, J6a,6b = 12.5 Hz, J5,6a = 2.0 Hz, H-6a), 3.74
(dd, 1.0H, J5,6b = 5.6 Hz, H-6b), 3.56−3.49 (m, 2.0H, H-3, H-5),
3.44−3.34 (m, 2.0H, H-2, H-4); 13C{1H} NMR (101 MHz, D2O) δ
166.2 (C-4″), 151.8 (C-2′′), 141.6 (C-6′′), 102.5 (C-5′′), 97.8 (C-1),
88.5 (C-1′), 83.2 (C-4′), 76.4, 75.3 (C-3, C-5), 73.7 (C-2′), 73.5 (C-
2), 69.7 (C-3′), 69.3 (C-4), 64.8 (C-5′), 60.6 (C-6); 31P NMR (162
MHz, D2O) δ −1.81 (d, JP,P = 4.86 Hz); HRMS (ESI/Q-TOF) m/z
−
[M − H]− calcd for C15H22N2O14P1 485.0814, found 485.0802.
Uridine 5′-Diphospho-αβ-D-galactose, 3. D-Galactose (25 mg,
139 μmol) was dissolved in H2O/CH3CN (2:1, 600 μL), and DMC
(70 mg, 416 μmol) dissolved in H2O/CH3CN (2:1, 50 μL) was
added to the resulting solution. Subsequently, Et3N (232 μL, 1.80
mmol) and UDP (62 mg, 139 μmol) were added to the solution, and
the mixture was stirred at 4 °C for 1 d. The reaction mixture was
purified by silica gel chromatography using a solvent composition and
gradient of 9:2:1 → 8:2:1 → 7:2:1 → 6:2:1 (v/v/v) ethyl acetate/
methanol/H2O. The absorbance of each fraction was measured at 262
nm, and the combined fractions were evaporated. The obtained
powders were identified and then collected to afford UDP-galactose 3
(16 mg, 21%, α/β = 1:1.9). UDP-galactose 3 (α:β = 1:13): 1H NMR
(400 MHz, D2O) δ 7.96 (d, 1.1H, J5″,6′′ = 8.1 Hz, H-6″), 6.00−5.98
(m, 2.2H, H-1′, H-5′′), 5.66 (dd, 0.1H, J1,P = 7.2 Hz, J1,2 = 3.6 Hz, H-
1α), 4.97 (br d, 1.0H, J1,P = 7.8 Hz, J1,2 = 7.8 Hz, H-1β), 4.41−4.38
(m, 2.2H, H-2′, H-3′), 4.30−4.20 (m, 3.3H, H-4′, H-5a′, H-5b′),
4.04−4.03 (br d, 0.1H, H-4α), 3.94−3.93 (br d, 1.0H, H-4β), 3.85−
3.69 (m, 4.2H, H-3β, H-5β, H-6aβ, H-6bβ, H-2α, H-3α), 3.63 (dd,
1.2H, J2,3 = 10.0 Hz, H-2β, H-6aα, H-6bα); 13C{1H} NMR (101
MHz, D2O) δ 166.3 (C-4″), 151.9 (C-2′′), 141.6 (C-6′′), 102.7 (C-
5′′), 98.5 (C-1β), 88.3 (C-1′), 83.3, 83.2 (C-4′), 75.9 (C-5), 73.7 (C-
2′), 72.3 (C-3), 71.3, 71.2 (C-2), 69.7 (C-3′), 68.6 (C-4), 65.1, 65.0
(C-5′), 61.2 (C-6), 46.7 (NCH2), 8.2 (CH3); 31P NMR (162 MHz,
D2O) δ −11.51 (d, JP,P = 14.6 Hz), −13.82 (d); HRMS (ESI/Q-
General Procedure for Investigating of the Effect of UDP
Equivalents (Table 3). The sugar (11 μmol) was dissolved in H2O/
CH3CN (2:1, 44 μL), and 3.3 equiv of DMC (36 μmol) dissolved in
H2O/CH3CN (2:1, 22 μL) was added. Subsequently, Et3N (220, 165,
or 136 μmol) and UDP (55, 34, or 11 μmol) were added to the
solution, and the mixture was stirred until all of the components had
completely dissolved. After stirring at 4 °C for 1 h, the reaction
mixture was collected and diluted 100 times with water. The diluted
solution was analyzed using HPLC to calculate the product yields.
Preparation of the Sugar Nucleotides. Uridine 5′-Diphospho-
αβ-D-glucopyranose, 1. D-Glucose (27 mg, 150 μmol) was dissolved
in D2O/CH3CN (2:1, 400 μL), and DMC (76 mg, 450 μmol)
dissolved in D2O/CH3CN (2:1, 200 μL) was added to the resulting
solution. Subsequently, Et3N (251 μL, 1.80 mmol) and UDP (68 mg,
152 μmol) were added to the solution, and the mixture was stirred at
4 °C for 3 days. The reaction mixture was then divided into 351 μL
portions for analysis and 500 μL for separation. The 500 μL aliquot
was purified by silica gel chromatography using a solvent composition
and gradient of 9:2:1 → 8:2:1 → 6:2:1 (v/v/v) ethyl acetate/
methanol/H2O. The absorbance of each fraction was measured at 262
nm, and the combined fractions were evaporated to give UDP-glucose
−
TOF) m/z [M − H]− calcd for C15H23N2O17P2 565.0477, found
565.0478.
Uridine 5′-Diphospho-α-D-mannopyranose, 4. D-Mannose (27
mg, 149 μmol) was dissolved in H2O/CH3CN (2:1, 400 μL), and
DMC (77 mg, 454 μmol) dissolved in H2O/CH3CN (2:1, 200 μL)
was added to the resulting solution. Subsequently, Et3N (251 μL, 1.80
mmol) and UDP (67 mg, 150 μmol) were added to the solution, and
the mixture was stirred at 4 °C for 1 day. The reaction mixture was
then divided into 351 μL and 500 μL portions for analysis and
separation, respectively. The 500 μL portion was purified by silica gel
chromatography using a solvent composition and gradient of 9:2:1 →
8:2:1 → 6:2:1 → 5:2:1 → 4:2:1 → 3:2:1 → 2:2:1 (v/v/v) ethyl
acetate/methanol/H2O. The absorbance of each fraction was
measured at 262 nm, and the combined fractions were evaporated
to give UDP-mannose 4 (10 mg, 20%): 1H NMR (400 MHz, D2O) δ
7.96 (d, 1.0H, J5″,6′′ = 8.0 Hz, H-6″), 6.00−5.97 (m, 2.0H, H-1′, H-
5′′), 5.53 (dd, 1.0H, J1,2 = 1.6 Hz, J1,P = 7.6 Hz, H-1), 4.39−4.35 (m,
2.0H, H-2′, H-3′), 4.30−4.17 (m, 3.0H, H-4′, H-5a′, H-5b′), 4.06−
4.04 (m, 1.0H, H-2), 3.94−3.84 (m, 3.0H, H-3, H-5, H-6a), 3.77 (dd,
1
1 (15 mg, 30%, α/β = 1:17): H NMR (400 MHz, D2O) δ 7.95 (d,
1.0H, J5″,6′′ = 8.0 Hz, H-6″), 6.00−5.98 (m, 2.1H, H-1′, H-5′′), 5.62
(dd, 0.1H, J1α,P = 7.2 Hz, J1α,2 = 3.6 Hz, H-1α), 5.03 (dd, 1.0H, J1β,P
=
7.9 Hz, J1β,2 = 7.9 Hz, H-1β), 4.40−4.36 (m, 2.1H, H-2′, H-3′), 4.29−
4.18 (m, 3.2H, H-4′, H-5a′, H-5b′), 3.92 (dd, 1.0H, J6a,6b = 12.4 Hz,
J
5,6a = 2.0 Hz, H-6a), 3.72 (dd, 1.0H, J5,6b = 6.4 Hz, H-6b), 3.57−3.50
(m, 2.1H, H-3, H-5), 3.42−3.37 (m, 2.1H, H-2, H-4); 13C{1H} NMR
(101 MHz, D2O) δ 166.2 (C-4″), 151.8 (C-2′′), 141.6 (C-6′′), 102.7
(C-5′′), 97.9 (C-1), 88.4 (C-1′), 83.2 (C-4′), 76.5, 75.2 (C-3, C-5),
E
J. Org. Chem. XXXX, XXX, XXX−XXX